St Olavs Hospital
Trondheim, Norway
NCT Number: NCT02494947
The primary purpose of this study is to investigate if systematic, high intensity, interval-based aerobic exercise training results in regression of lipid content of atherosclerotic coronary artery plaques, and in reduction of plaque burden in patients with stable coronary heart disease. Composition and morphologic characteristics of plaques will be studied by intra-coronary near-infrared spectroscopy (NIRS) and intravascular ultrasound (IVUS) in patients undergoing percutaneous coronary intervention.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Trondheim, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Interval exercises done 3 times weekly during 6 months according to standard procedures at the Department of Circulation and Medical Imaging.
Time frame: 6 months
Lipid core burden index (LCBI) measured by intracoronary near-infrared spectroscopy
Norwegian University of Science and Technology
Other
Physical Activity and Lipid Content of Coronary Artery Atheromatous Plaques: a Randomised Trial Using Novel Intracoronary Imaging Techniques
Acronym: CENIT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05705310
Behavior, Cardiovascular Diseases
Belfast, United Kingdom
View Trial DetailsNCT04732923
Acute Coronary Syndrome, Behavior
Cholet, France
View Trial DetailsNCT02802254
Behavior, Cardiac Diseases
Hamburg, Germany
View Trial DetailsNCT00411359
Angina Pectoris, Behavior
London, United Kingdom
View Trial Details